US Stem Cell Inc (USRM)

[gypsydoc]

Good article from NEJM. It does in fact share the reality of stem cell activity in the USA. It does describe an array of yet unresolved controversies on both sides of the regulator vs. provider equation. And, it does tell, like Ive shared before, the story about the fact that there is a significant market for musculo-skeletal stem cell treatments. Big revenue is being generated and BHRT/US Stem Cell participates in and is benefiting from the growing activity. While some try to shut it down, equally strong are the promoters of this service. While dangers are speculative and undocumented, there is more than enough satisfaction from those who utilize and provide the treatment to perpetuate continued provision of service, and IMO accomplish creating an appropriate regulatory structure to allow and grow ongoing stem cell treatment to that segment of the public that wishes to take advantage. Finally, the revenue generated from this service is big - really big - and it is what will carry this and other companies participating in the stem cell marketplace to success.